169 related articles for article (PubMed ID: 9856569)
1. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
Kim HT; Choi BH; Niikawa N; Lee TS; Chang SI
Am J Med Genet; 1998 Dec; 80(4):391-5. PubMed ID: 9856569
[TBL] [Abstract][Full Text] [Related]
2. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues.
Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM
Digestion; 1999; 60(5):477-83. PubMed ID: 10473973
[TBL] [Abstract][Full Text] [Related]
3. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
4. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
[TBL] [Abstract][Full Text] [Related]
5. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
Yballe CM; Vu TH; Hoffman AR
J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
[TBL] [Abstract][Full Text] [Related]
6. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
[TBL] [Abstract][Full Text] [Related]
7. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma.
Wu MS; Wang HP; Lin CC; Sheu JC; Shun CT; Lee WJ; Lin JT
Cancer Lett; 1997 Nov; 120(1):9-14. PubMed ID: 9570380
[TBL] [Abstract][Full Text] [Related]
8. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors.
Ross JA; Schmidt PT; Perentesis JP; Davies SM
Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147
[TBL] [Abstract][Full Text] [Related]
9. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
10. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma.
Kim KS; Lee YI
Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364
[TBL] [Abstract][Full Text] [Related]
11. Genomic imprinting of IGF2 and H19 in human meningiomas.
Müller S; Zirkel D; Westphal M; Zumkeller W
Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131
[TBL] [Abstract][Full Text] [Related]
12. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma.
Albrecht S; Waha A; Koch A; Kraus JA; Goodyer CG; Pietsch T
J Neuropathol Exp Neurol; 1996 Dec; 55(12):1270-6. PubMed ID: 8957451
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of igf2 in renal-cell carcinomas.
Oda H; Kume H; Shimizu Y; Inoue T; Ishikawa T
Int J Cancer; 1998 Jan; 75(3):343-6. PubMed ID: 9455791
[TBL] [Abstract][Full Text] [Related]
14. IGF2 but not H19 shows loss of imprinting in human glioma.
Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
[TBL] [Abstract][Full Text] [Related]
15. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma.
Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A
Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994
[TBL] [Abstract][Full Text] [Related]
16. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.
Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK
Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082
[TBL] [Abstract][Full Text] [Related]
17. Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas.
Rainho CA; Pontes A; Rogatto SR
Gynecol Oncol; 1999 Sep; 74(3):375-80. PubMed ID: 10479496
[TBL] [Abstract][Full Text] [Related]
18. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer.
Tanos V; Prus D; Ayesh S; Weinstein D; Tykocinski ML; De-Groot N; Hochberg A; Ariel I
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):7-11. PubMed ID: 10428315
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma.
Lawson EA; Zhang X; Crocker JT; Wang WL; Klibanski A
J Clin Endocrinol Metab; 2009 Jul; 94(7):2226-31. PubMed ID: 19383775
[TBL] [Abstract][Full Text] [Related]
20. Imprinting of IGF2 and H19: lack of reciprocity in sporadic Beckwith-Wiedemann syndrome.
Joyce JA; Lam WK; Catchpoole DJ; Jenks P; Reik W; Maher ER; Schofield PN
Hum Mol Genet; 1997 Sep; 6(9):1543-8. PubMed ID: 9285792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]